H& PC Today: How was 2014 for Sabinsa in terms of revenue? Business

The past few years we have seen moderate to high growth, spanning all of our divisions, from Nutraceuticals (standardized herbal extracts), to Cosmeceuticals and functional foods. Our fl avors & fragrance division is also on track for showing increased revenues. The business is really coming from ingredients that Sabinsa has studied over the years, pouring money into their research, usage, formulation techniques and of course protecting them intellectually, meaning trademarks and patents.

We started 2014 under a great deal of care and concern over competitors infringing on Sabinsa’s key patented and branded Curcumin ingredient, Curcumin C3 Complex ® , which we were monitoring closely. This ingredient in fact enjoyed great attention in the clinical arena in 2014 with studies focused on Osteoarthritis showing very positive and signifi cant results, in addition to one of the most talked about studies done on Curcumin, the Lipid-modifying effects of adjunctive therapy in patients with metabolic syndrome.

Needless to say, our passion concerning Curcumin is more about the evidence rather than hype or even providing the market with altered/modifi ed forms of Curcumin talking about some percentage of increase in bioavailability – which we all will soon learn was much too over hyped with unnecessary commotion...